Transcriptional and post-transcriptional mechanisms of BAFF-receptor dysregulation in human B lineage malignancies

Stephen A. Mihalcik, Renee C. Tschumper, Diane F Jelinek

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Together, circulating BAFF and dominant receptor BAFF-R homeostatically regulate the humoral immune system. Consistently aberrant BAFF-R expression in leukemic cells reveals an intimate connection of these cells' malignant physiology to the BAFF/BAFF-R axis and also provides an additional survival mechanism to the expressing cells. In this study, we used primary cells and cell lines to interrogate the mechanisms underlying aberrant BAFF-R expression in precursor B acute lymphoblastic leukemia (precursor B-ALL) and mature B chronic lymphocytic leukemia (CLL). Here we demonstrate the aberrant expression of BAFF-R in precursor B-ALL cell lines and reveal that these cells acquire BAFF-R expression through premature transcriptional activation of the BAFF-R promoter in coordination with regulatory transcription factor c-Rel. Investigations using primary CLL cells provide a crucial counterpoint through their paucity of BAFF-R relative to their benign mature B cell counterparts, which we establish as functionally significant in its depletion of the CLL cells' BAFF-binding capacity. Furthermore, BAFF-R downregulation in CLL patients is revealed here to be restricted to the malignant compartment and mediated post-transcriptionally in order to compensate for the consistently unchanged levels of transcription factor c-Rel and BAFF-R mRNA. Finally, we present evidence that CLL cells retain endogenous mechanisms of BAFF-R regulatory control despite active receptor dysregulation.

Original languageEnglish (US)
Pages (from-to)4884-4892
Number of pages9
JournalCell Cycle
Volume9
Issue number24
DOIs
StatePublished - Dec 15 2010

Fingerprint

B-Cell Activation Factor Receptor
B-Cell Chronic Lymphocytic Leukemia
Neoplasms
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Transcription Factors
Cell Line
Cell Physiological Phenomena
Transcriptional Activation
Immune System
B-Lymphocytes
Down-Regulation
Messenger RNA

Keywords

  • Acute lymphoblastic leukemia
  • BAFF
  • Baff receptor
  • c-Rel
  • Chronic lymphocytic leukemia

ASJC Scopus subject areas

  • Cell Biology
  • Developmental Biology
  • Molecular Biology

Cite this

Transcriptional and post-transcriptional mechanisms of BAFF-receptor dysregulation in human B lineage malignancies. / Mihalcik, Stephen A.; Tschumper, Renee C.; Jelinek, Diane F.

In: Cell Cycle, Vol. 9, No. 24, 15.12.2010, p. 4884-4892.

Research output: Contribution to journalArticle

@article{28ac332928bd4e51826bd26e68037879,
title = "Transcriptional and post-transcriptional mechanisms of BAFF-receptor dysregulation in human B lineage malignancies",
abstract = "Together, circulating BAFF and dominant receptor BAFF-R homeostatically regulate the humoral immune system. Consistently aberrant BAFF-R expression in leukemic cells reveals an intimate connection of these cells' malignant physiology to the BAFF/BAFF-R axis and also provides an additional survival mechanism to the expressing cells. In this study, we used primary cells and cell lines to interrogate the mechanisms underlying aberrant BAFF-R expression in precursor B acute lymphoblastic leukemia (precursor B-ALL) and mature B chronic lymphocytic leukemia (CLL). Here we demonstrate the aberrant expression of BAFF-R in precursor B-ALL cell lines and reveal that these cells acquire BAFF-R expression through premature transcriptional activation of the BAFF-R promoter in coordination with regulatory transcription factor c-Rel. Investigations using primary CLL cells provide a crucial counterpoint through their paucity of BAFF-R relative to their benign mature B cell counterparts, which we establish as functionally significant in its depletion of the CLL cells' BAFF-binding capacity. Furthermore, BAFF-R downregulation in CLL patients is revealed here to be restricted to the malignant compartment and mediated post-transcriptionally in order to compensate for the consistently unchanged levels of transcription factor c-Rel and BAFF-R mRNA. Finally, we present evidence that CLL cells retain endogenous mechanisms of BAFF-R regulatory control despite active receptor dysregulation.",
keywords = "Acute lymphoblastic leukemia, BAFF, Baff receptor, c-Rel, Chronic lymphocytic leukemia",
author = "Mihalcik, {Stephen A.} and Tschumper, {Renee C.} and Jelinek, {Diane F}",
year = "2010",
month = "12",
day = "15",
doi = "10.4161/cc.9.24.14156",
language = "English (US)",
volume = "9",
pages = "4884--4892",
journal = "Cell Cycle",
issn = "1538-4101",
publisher = "Landes Bioscience",
number = "24",

}

TY - JOUR

T1 - Transcriptional and post-transcriptional mechanisms of BAFF-receptor dysregulation in human B lineage malignancies

AU - Mihalcik, Stephen A.

AU - Tschumper, Renee C.

AU - Jelinek, Diane F

PY - 2010/12/15

Y1 - 2010/12/15

N2 - Together, circulating BAFF and dominant receptor BAFF-R homeostatically regulate the humoral immune system. Consistently aberrant BAFF-R expression in leukemic cells reveals an intimate connection of these cells' malignant physiology to the BAFF/BAFF-R axis and also provides an additional survival mechanism to the expressing cells. In this study, we used primary cells and cell lines to interrogate the mechanisms underlying aberrant BAFF-R expression in precursor B acute lymphoblastic leukemia (precursor B-ALL) and mature B chronic lymphocytic leukemia (CLL). Here we demonstrate the aberrant expression of BAFF-R in precursor B-ALL cell lines and reveal that these cells acquire BAFF-R expression through premature transcriptional activation of the BAFF-R promoter in coordination with regulatory transcription factor c-Rel. Investigations using primary CLL cells provide a crucial counterpoint through their paucity of BAFF-R relative to their benign mature B cell counterparts, which we establish as functionally significant in its depletion of the CLL cells' BAFF-binding capacity. Furthermore, BAFF-R downregulation in CLL patients is revealed here to be restricted to the malignant compartment and mediated post-transcriptionally in order to compensate for the consistently unchanged levels of transcription factor c-Rel and BAFF-R mRNA. Finally, we present evidence that CLL cells retain endogenous mechanisms of BAFF-R regulatory control despite active receptor dysregulation.

AB - Together, circulating BAFF and dominant receptor BAFF-R homeostatically regulate the humoral immune system. Consistently aberrant BAFF-R expression in leukemic cells reveals an intimate connection of these cells' malignant physiology to the BAFF/BAFF-R axis and also provides an additional survival mechanism to the expressing cells. In this study, we used primary cells and cell lines to interrogate the mechanisms underlying aberrant BAFF-R expression in precursor B acute lymphoblastic leukemia (precursor B-ALL) and mature B chronic lymphocytic leukemia (CLL). Here we demonstrate the aberrant expression of BAFF-R in precursor B-ALL cell lines and reveal that these cells acquire BAFF-R expression through premature transcriptional activation of the BAFF-R promoter in coordination with regulatory transcription factor c-Rel. Investigations using primary CLL cells provide a crucial counterpoint through their paucity of BAFF-R relative to their benign mature B cell counterparts, which we establish as functionally significant in its depletion of the CLL cells' BAFF-binding capacity. Furthermore, BAFF-R downregulation in CLL patients is revealed here to be restricted to the malignant compartment and mediated post-transcriptionally in order to compensate for the consistently unchanged levels of transcription factor c-Rel and BAFF-R mRNA. Finally, we present evidence that CLL cells retain endogenous mechanisms of BAFF-R regulatory control despite active receptor dysregulation.

KW - Acute lymphoblastic leukemia

KW - BAFF

KW - Baff receptor

KW - c-Rel

KW - Chronic lymphocytic leukemia

UR - http://www.scopus.com/inward/record.url?scp=78650350279&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650350279&partnerID=8YFLogxK

U2 - 10.4161/cc.9.24.14156

DO - 10.4161/cc.9.24.14156

M3 - Article

VL - 9

SP - 4884

EP - 4892

JO - Cell Cycle

JF - Cell Cycle

SN - 1538-4101

IS - 24

ER -